Late breaking presentation of the Phase 2b long-term findings on the investigational molecule, bimekizumab, demonstrates complete or almost complete skin clearance in moderate-to-severe plaque...

Par Pacific Holdings, Inc. (NYSE: PARR) ("Par Pacific") today announced that Bill Pate, Par Pacific's Chief Executive Officer, will attend the Bank of America Merrill Lynch 2019 Refining Conference in

After the phenomenal success of AD ART SHOW 2018 at Sotheby's, NBCUniversal is returning as presenting partner for AD ART SHOW 2019—MvVO ART's new annual addition to the art scene in New York...

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the companies will present a diverse set of clinical and real-world data at the 2019 American Academy of Dermatology...

AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced today that the Company will be presenting mechanism of action findings and study design...